# Study to Evaluate the Superior Efficacy of Cardiac Resynchronization (SyncAVTM) Using the SyncAVTM Algorithm

> **NCT03961399** · NA · COMPLETED · sponsor: **Hospital Universitari Vall d'Hebron Research Institute** · enrollment: 56 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **DEVICE:** Abbott Medical® CRT device with SyncAVTM stimulation function
- **DEVICE:** Abbott Medical® CRT device with biventricular stimulation (BiV)

## Key facts

- **NCT ID:** NCT03961399
- **Lead sponsor:** Hospital Universitari Vall d'Hebron Research Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-18
- **Primary completion:** 2021-10-27
- **Final completion:** 2021-10-27
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2023-10-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03961399

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03961399, "Study to Evaluate the Superior Efficacy of Cardiac Resynchronization (SyncAVTM) Using the SyncAVTM Algorithm". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03961399. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*